Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Williams

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Environmental Microbiology|August 14, 2012
Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infectionsV Behrends, B Ryall, J E A Zlosnik, et al.
Neurosurgery|October 1, 1983
Severe cerebral ischemia treatment by ventriculosubarachnoid perfusion with an oxygenated fluorocarbon emulsionJ L Osterholm, J B Alderman, A J Triolo, et al.
Plos One|January 10, 2019
In vitro and in vivo properties of the bovine antimicrobial peptide, Bactenecin 5R L Price, L Bugeon, S Mostowy, et al.
Endocrine-Related Cancer|August 23, 2005
Development of strategies for the use of anti-growth factor treatmentsH E Jones, J M W Gee, K M Taylor, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Environmental Microbiology|August 14, 2012
Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infectionsV Behrends, B Ryall, J E A Zlosnik, et al.
Neurosurgery|October 1, 1983
Severe cerebral ischemia treatment by ventriculosubarachnoid perfusion with an oxygenated fluorocarbon emulsionJ L Osterholm, J B Alderman, A J Triolo, et al.
Plos One|January 10, 2019
In vitro and in vivo properties of the bovine antimicrobial peptide, Bactenecin 5R L Price, L Bugeon, S Mostowy, et al.
Endocrine-Related Cancer|August 23, 2005
Development of strategies for the use of anti-growth factor treatmentsH E Jones, J M W Gee, K M Taylor, et al.
Pageof 4